Previous close | 0.6611 |
Open | 0.6611 |
Bid | 0.6700 x 1000 |
Ask | 0.7069 x 800 |
Day's range | 0.6525 - 0.7003 |
52-week range | 0.4900 - 1.5800 |
Volume | |
Avg. volume | 374,200 |
Market cap | 58.97M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1030 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 11.13 |
ATLANTA, January 26, 2023--Alzamend Neuro to Present at Sequire Biotechnology Conference on Thursday, February 2, 2023; Highlighting Alzamend’s Achievements This Past Year
ATLANTA, January 04, 2023--Alzamend Neuro Partners With Biorasi to Conduct First-in-Human, Randomized, Double-Blind Placebo-Controlled Parallel Group Phase I/IIA Clinical Trial
ATLANTA, December 28, 2022--Alzamend Neuro Partners with Miller School of Medicine at the University of Miami for ALZN002 Phase I/IIA Immunotherapy Vaccine Clinical Trial for AD